Figure 3.
Unadjusted Kaplan Meier estimate of the cumulative event-free survival in the non-SA and SAA341V groups. Any cardiac event (syncope, cardiac arrest or LQTS-related sudden cardiac death), whichever occurred first, was considered from birth through age 40 years and before β-blocker therapy. Numbers at risk are indicated. (From ref. 29)